• Federal
  • DOT · Federal
  • Urine
  • Oral fluid

Opioids on a Drug Test: Which Ones, and at What Cutoffs

Short answer

The federal panel does not test for “opioids” as one thing. It tests named pairs at four different cutoffs: codeine and morphine at 2,000 ng/mL for both screening and confirmation; hydrocodone and hydromorphone at 300 and 100; oxycodone and oxymorphone at 100 and 100; and 6-acetylmorphine, which points specifically at heroin, at 10 and 10 [1]. Fentanyl is not on the DOT panel [1][2].

Last verified 18 Aug 2026

What matters most

  • Codeine and morphine: 2,000 ng/mL screening and confirmatory.
  • Hydrocodone and hydromorphone: 300 screening, 100 confirmatory.
  • Oxycodone and oxymorphone: 100 screening, 100 confirmatory.
  • 6-acetylmorphine, specific to heroin: 10 ng/mL both stages.
  • Fentanyl is not on the DOT panel. The proposal to add it has not taken effect.

Four lines, not one drug

On an older panel, “opiates” meant codeine, morphine, and heroin. The current federal panel is wider and more specific, and each pair carries its own numbers Source 1eCFR49 CFR §40.85 (current text) — checked 17 Aug 2026:

  • Codeine and morphine - 2,000 ng/mL to screen, 2,000 ng/mL to confirm
  • Hydrocodone and hydromorphone - 300 to screen, 100 to confirm
  • Oxycodone and oxymorphone - 100 to screen, 100 to confirm
  • 6-acetylmorphine - 10 to screen, 10 to confirm

The spread is the point. Codeine and morphine are twenty times higher than oxycodone, so a reading that clears one pair tells you nothing at all about another.

Why 6-acetylmorphine is the specific one

6-acetylmorphine is a heroin metabolite. Morphine in a specimen can have come from more than one place; 6-AM is the marker that points to heroin in particular, and it carries the lowest cutoff on the panel at 10 ng/mL in both stages Source 1eCFR49 CFR §40.85 (current text) — checked 17 Aug 2026.

Fentanyl is not on the DOT panel

Federal (DOT): fentanyl and norfentanyl are absent from the cutoff table in the current regulation Source 1eCFR49 CFR §40.85 (current text) — checked 17 Aug 2026. DOT has proposed adding fentanyl to the panel, and that proposal has not taken effect Source 2Federal RegisterNPRM — Addition of Fentanyl to the DOT Testing Panel — checked 17 Aug 2026. We re-checked the regulation on 18 August 2026, and it remains as amended in May 2023.

If someone tells you a DOT test covers fentanyl today, they are describing a proposal rather than the rule.

Prescriptions are the common case

Most opioid positives have a prescription behind them. As with any analyte, the medical review officer considers whether there is a legitimate medical explanation before a laboratory positive is verified Source 3eCFR49 CFR Part 40 — Procedures for Transportation Workplace Drug and Alcohol Testing Programs — checked 17 Aug 2026. And that is where the prescription and its documentation belong.

The EEOC has published guidance for employees on codeine, oxycodone, and other opioids Source 4EEOCUse of Codeine, Oxycodone, and Other Opioids: Information for Employees — checked 17 Aug 2026. Two limits on it are worth knowing before you rely on it: it is technical assistance and does not carry the force of law, and it does not address DOT or safety-sensitive roles. If you are in a regulated job, it is not your document.

What a number above a cutoff does not establish

A concentration above a cutoff is not a measure of impairment, of dose, or of when a substance was taken. The cutoffs exist to separate a reportable result from an unreportable one, and that is all they do Source 1eCFR49 CFR §40.85 (current text) — checked 17 Aug 2026Source 5HHSMandatory Guidelines for Federal Workplace Drug Testing Programs — Authorized Testing Panels — checked 17 Aug 2026.

What this means for you

If you take a prescribed opioid, the useful preparation is documentation and the verification interview. It is not a search for how long it stays detectable, which no agency publishes [3].

And if you are checking whether fentanyl is covered, it is not on the DOT panel, as of the date on this page [1][2]. That one is worth re-checking rather than remembering.

Note the limitation before relying on either: home panels read OPI at 2000 ng/mL, so a five- or seven-substance card covers morphine and codeine but will not reliably show the semi-synthetics discussed above.

Rules differ by state and employer. This section describes federal requirements. Your state law or your employer’s written policy may add rules on top of them.

When the answer changes

Methadone and buprenorphine are not on the DOT panel either [1]. Non-regulated employers may include them in a wider panel; whether they do is a matter of their written policy, not federal law.

The oral fluid panel is expressed differently from urine, and when a specimen type changes, the numbers change with it. Do not replace a urine cutoff for a swab one.

Official sources

Every factual claim above is drawn from these sources. Each was opened and checked on the date shown. Where a rule differs between agencies, the source that governs is named in the text.

  1. eCFR · 49 CFR §40.85 (eCFR)

    49 CFR §40.85 (current text)

    Checked 17 Aug 2026
    View official source ↗ (opens in a new tab)
  2. Federal Register · DOT NPRM — fentanyl (proposed)

    NPRM — Addition of Fentanyl to the DOT Testing Panel

    Published 02 Sep 2025 · Checked 17 Aug 2026
    View official source ↗ (opens in a new tab)
  3. eCFR · 49 CFR Part 40 (eCFR)

    49 CFR Part 40 — Procedures for Transportation Workplace Drug and Alcohol Testing Programs

    Checked 17 Aug 2026
    View official source ↗ (opens in a new tab)
  4. EEOC · EEOC — opioids and employees (2020)

    Use of Codeine, Oxycodone, and Other Opioids: Information for Employees

    Published 05 Aug 2020 · Checked 17 Aug 2026
    View official source ↗ (opens in a new tab)
  5. HHS · HHS Mandatory Guidelines (2026)

    Mandatory Guidelines for Federal Workplace Drug Testing Programs — Authorized Testing Panels

    Effective 07 Jul 2025 · Published 13 Mar 2026 · Checked 17 Aug 2026
    View official source ↗ (opens in a new tab)

From Exploro

Test for this at home

A home test is a screening step. It tells you whether a substance is above or below that test’s cutoff — not how much, and not what a laboratory would report.

Exploro makes these tests. Star ratings are from Amazon customer reviews and are refreshed periodically; current prices and full instructions are on each product page.